Table 1. Clinical Characteristics of PD Subjects at Baseline.
Characteristics | Zero Intensity | Low Intensity | High Intensity |
---|---|---|---|
Patients (n) | 10 | 10 | 10 |
Sex (male/female) | 8/2 | 5/5 | 6/4 |
Age (y) | 63.1±11.5 | 61.5±9.8 | 64.0±14.5 |
Hoehn and Yahr stage | 1.9±0.3 | 1.9±0.3 | 1.9±0.5 |
Duration of PD (mo) | 17.7±13.3 | 8.8±7.9 | 14.7±9.9 |
MMSE score | 29.6±0.7 | 29.3±0.8 | 28.9±1.1 |
Medications | |||
Levodopa (mg) | 90.0±202.5 | 15.0±47.4 | 115.0±226.1 |
Pramipexole (mg) | 0.5±0.7 | 0.3±0.9 | 0.5±.1.0 |
Ropinerole (mg) | 0 | 0 | 1.6±5.1 |
Amantadine | 30.0±94.9 | 20.0±63.2 | 30.0±94.8 |
Selegiline | 0.5±1.6 | 1.0±3.2 | 1.0±2.1 |
NOTE. Values are mean ± SD.